Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo

BACKGROUND: Ovarian cancer is the most leading cause of death and the third most common gynecologic malignancy in women. Traditional chemotherapy has inevitable drawbacks of nonspecific tumor targeting, high toxicity, and poor therapeutic efficiency. In order to overcome such shortcomings, we prepar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Shu, Li, Li, Su, Xuan-tao, Wang, Kai, Lu, Zai-jun, Yuan, Cun-zhong, Feng, Jin-bo, Yan, Shi, Kong, Bei-hua, Song, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389131/
https://www.ncbi.nlm.nih.gov/pubmed/29478415
http://dx.doi.org/10.1186/s13046-018-0700-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389131/
https://www.ncbi.nlm.nih.gov/pubmed/29478415
http://dx.doi.org/10.1186/s13046-018-0700-z

Ejemplares similares